Lista de obras - Núria Climent - Dominio Público Uruguay

A gene (wbbL) from Serratia marcescens N28b (O4) complements the rfb-50 mutation of Escherichia coli K-12 derivatives.

artículo científico publicado en 1997

A therapeutic dendritic cell-based vaccine for HIV-1 infection

artículo científico publicado en 2011

Adenosine deaminase enhances T-cell response elicited by dendritic cells loaded with inactivated HIV.

artículo científico publicado en 2009

Adenosine deaminase enhances the immunogenicity of human dendritic cells from healthy and HIV-infected individuals

artículo científico publicado en 2012

Adenosine deaminase potentiates the generation of effector, memory, and regulatory CD4+ T cells.

artículo científico publicado en 2010

Adenosine deaminase regulates Treg expression in autologous T cell-dendritic cell cocultures from patients infected with HIV-1.

artículo científico publicado en 2015

An old enzyme for current needs: adenosine deaminase and a dendritic cell vaccine for HIV.

artículo científico publicado en 2011

Assessment of migration of HIV-1-loaded dendritic cells labeled with 111In-oxine used as a therapeutic vaccine in HIV-1-infected patients

artículo científico publicado en 2009

CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse.

artículo científico publicado en 2005

Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells

artículo científico publicado en 2016

Dendrimers as nonviral vectors in dendritic cell-based immunotherapies against human immunodeficiency virus: steps toward their clinical evaluation.

artículo científico

Directing vaccine immune responses to mucosa by nanosized particulate carriers encapsulating NOD ligands

artículo científico publicado en 2015

Distinct gene expression profiling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC.

artículo científico publicado en 2007

Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines

article

Expression and function of the IL-2 receptor in activated human plasmacytoid dendritic cells

artículo científico publicado en 2007

Genetic characterization of the Klebsiella pneumoniae waa gene cluster, involved in core lipopolysaccharide biosynthesis

artículo científico publicado en 2001

HIV-1 upregulates intercellular adhesion molecule-1 gene expression in lymphoid tissue of patients with chronic HIV-1 infection

scientific article published on 01 November 2007

Human CD6 Down-Modulation following T-Cell Activation Compromises Lymphocyte Survival and Proliferative Responses

artículo científico publicado en 2017

Human immature monocyte-derived dendritic cells produce and secrete α-defensins 1-3

artículo científico publicado en 2007

Immunological dysfunction in HIV-1-infected individuals caused by impairment of adenosine deaminase-induced costimulation of T-cell activation.

artículo científico publicado en 2009

Impact of alpha-defensins1-3 on the maturation and differentiation of human monocyte-derived DCs. Concentration-dependent opposite dual effects.

artículo científico publicado en 2009

Impact of long-term antiretroviral therapy interruption and resumption on viral reservoir in HIV-1 infected patients.

artículo científico publicado en 2017

Increased alpha-defensins 1-3 production by dendritic cells in HIV-infected individuals is associated with slower disease progression

artículo científico publicado en 2010

Increased expression with differential subcellular location of cytidine deaminase APOBEC3G in human CD4(+) T-cell activation and dendritic cell maturation.

artículo científico publicado en 2016

Loading dendritic cells with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses.

artículo científico publicado en 2014

P10-13. Increased production of alpha-defensins 1–3 by dendritic cells in HIV-infected individuals is associated with a slower disease progression rate.

artículo científico publicado en 2009

P18-07. Ex vivo production of autologous HIV-1 to be used as immunogen in autologous dendritic cell-based therapeutic vaccine (clinical trial DCV02).

artículo científico publicado en 2009

P20-06. Study of viral variability evolution in patients submitted to a therapeutic vaccine based on autologous dendritic cells pulsed with autologous HIV-1

article

Selective induction of host genes by MVA-B, a candidate vaccine against HIV/AIDS

artículo científico publicado en 2010

Tacrolimus treatment of plasmacytoid dendritic cells inhibits dinucleotide (CpG-)-induced tumour necrosis factor-alpha secretion

scientific article published on 24 August 2006

Therapeutic Immunization with Dendritic Cells Loaded with Heat‐Inactivated Autologous HIV‐1 in Patients with Chronic HIV‐1 Infection

article

Lista de obras de Núria Climent

A gene (wbbL) from Serratia marcescens N28b (O4) complements the rfb-50 mutation of Escherichia coli K-12 derivatives.

A therapeutic dendritic cell-based vaccine for HIV-1 infection

Adenosine deaminase enhances T-cell response elicited by dendritic cells loaded with inactivated HIV.

Adenosine deaminase enhances the immunogenicity of human dendritic cells from healthy and HIV-infected individuals

Adenosine deaminase potentiates the generation of effector, memory, and regulatory CD4+ T cells.

Adenosine deaminase regulates Treg expression in autologous T cell-dendritic cell cocultures from patients infected with HIV-1.

An old enzyme for current needs: adenosine deaminase and a dendritic cell vaccine for HIV.

Assessment of migration of HIV-1-loaded dendritic cells labeled with 111In-oxine used as a therapeutic vaccine in HIV-1-infected patients

CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse.

Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells

Dendrimers as nonviral vectors in dendritic cell-based immunotherapies against human immunodeficiency virus: steps toward their clinical evaluation.

Directing vaccine immune responses to mucosa by nanosized particulate carriers encapsulating NOD ligands

Distinct gene expression profiling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC.

Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines

Expression and function of the IL-2 receptor in activated human plasmacytoid dendritic cells

Genetic characterization of the Klebsiella pneumoniae waa gene cluster, involved in core lipopolysaccharide biosynthesis

HIV-1 upregulates intercellular adhesion molecule-1 gene expression in lymphoid tissue of patients with chronic HIV-1 infection

Human CD6 Down-Modulation following T-Cell Activation Compromises Lymphocyte Survival and Proliferative Responses

Human immature monocyte-derived dendritic cells produce and secrete α-defensins 1-3

Immunological dysfunction in HIV-1-infected individuals caused by impairment of adenosine deaminase-induced costimulation of T-cell activation.

Impact of alpha-defensins1-3 on the maturation and differentiation of human monocyte-derived DCs. Concentration-dependent opposite dual effects.

Impact of long-term antiretroviral therapy interruption and resumption on viral reservoir in HIV-1 infected patients.

Increased alpha-defensins 1-3 production by dendritic cells in HIV-infected individuals is associated with slower disease progression

Increased expression with differential subcellular location of cytidine deaminase APOBEC3G in human CD4(+) T-cell activation and dendritic cell maturation.

Loading dendritic cells with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses.

P10-13. Increased production of alpha-defensins 1–3 by dendritic cells in HIV-infected individuals is associated with a slower disease progression rate.

P18-07. Ex vivo production of autologous HIV-1 to be used as immunogen in autologous dendritic cell-based therapeutic vaccine (clinical trial DCV02).

P20-06. Study of viral variability evolution in patients submitted to a therapeutic vaccine based on autologous dendritic cells pulsed with autologous HIV-1

Selective induction of host genes by MVA-B, a candidate vaccine against HIV/AIDS

Tacrolimus treatment of plasmacytoid dendritic cells inhibits dinucleotide (CpG-)-induced tumour necrosis factor-alpha secretion

Therapeutic Immunization with Dendritic Cells Loaded with Heat‐Inactivated Autologous HIV‐1 in Patients with Chronic HIV‐1 Infection